COMP <GO>
DOC vs BAC // PIOTROSKI F-SCORE QUALITY
Healthpeak Properties Inc. (NYSE) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: DOC 6
— BAC 8
▲ PIOTROSKI F-SCORE QUALITY LEADER: DOC
LAST: $19.03 (+0.48%) • MKT CAP: $13.06B
piotroski-score
8/9
LAST: $50.01 (-2.21%) • MKT CAP: $357.61B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DOC VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DOC | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.60% | 2.50% | -1.90 | BAC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 30.2x | +64.80 | BAC | /valuation <GO> |
| Free Cash Flow Yield | 9.38% | 2.10% | +7.28 | DOC | /fcf-yield <GO> |
| Operating Margin | 14.40% | 32.90% | -18.50 | BAC | /operating-margins <GO> |
| Net Profit Margin | 11.80% | 27.00% | -15.20 | BAC | /net-margins <GO> |
| Revenue Growth (YoY) | 6.20% | 6.80% | -0.60 | BAC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 6.50% | 0.00% | +6.50 | DOC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.12 | 0.45 | +0.67 | DOC | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 8/9 | 7/9 | +1.00 | DOC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.60% | +0.40 | BAC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.9 | 27.7 | +19.22 | DOC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.90 | +0.12 | DOC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 10.9x | +129.10 | BAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.06B | $357.61B | -$344.55B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DOC REV | BAC REV | DOC GROSS % | BAC GROSS % | DOC FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $604.0M | $113.10B | 44.0% | 44.0% | $1.22B | $7.52B |
| FY 2024 | $568.5M | $105.86B | -89.1% | 44.0% | $1.04B | -$13.57B |
| FY 2023 | $527.4M | $102.77B | 44.0% | 44.0% | $932.5M | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DOC // BETA 1.02
BAC // BETA 0.90